Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2CNS 2Gastrointestinal 1

Conditions

Central Nervous System Neoplasms 107Neuroblastoma 64Brain Neoplasms 64Astrocytoma 59Glioblastoma 52Oligodendroglioma 42Medulloblastoma 36Gliosarcoma 34Glioma 28Optic Nerve Glioma 20Familial ependymoma 19Choroid Plexus Neoplasms 19Sarcoma 15Rhabdoid Tumor 15Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Osteosarcoma 12Neoplasm Metastasis 12Ependymoma 12Meningioma 11Recurrence 10Melanoma 10Spinal Cord Neoplasms 9Leukemia 9Burkitt Lymphoma 9Testicular Neoplasms 8Ovarian Neoplasms 8Neoplasms 8Dendritic Cell Sarcoma, Interdigitating 8Wilms Tumor 7

Interventions

lorvotuzumab mertansine 1Polymerase Chain Reaction 1Gene Rearrangement 1Gene Expression Profiling 1Cytogenetic Analysis 1Amplified Fragment Length Polymorphism Analysis 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Pleuropulmonary blastoma × CNS × Clear all
NCT02452554 2022-01-13

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Children's Oncology Group

Phase 2 Completed
62 enrolled 15 charts
CNSGenitourinarySarcoma

Pleuropulmonary blastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Synovial, Neurofibrosarcoma

NCT01353300 2016-07-11

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Children's Oncology Group

Completed
31 enrolled
CNSGastrointestinalGenitourinarySarcoma

Pleuropulmonary blastoma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡